Trials / Withdrawn
WithdrawnNCT04127318
Low-moderate Intensity Pedaling During Immunotherapy Administration
Evaluating the Effects of Low-moderate Intensity Pedaling During Immunotherapy Administration on Immune Biomarkers and Quality of Life
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Rush University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the feasibility pedaling using an under-the desk bike during immunotherapy infusions. Also, the study hopes to evaluate how pedaling impacts quality of life and treatment response biomarkers. Lastly, the study will evaluate the relationships between treatment response and muscle mass which is evaluated with computerized tomography (CT) scans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Pedaling Group | Participants will pedal at low-moderate intensity using a stationary pedal ergometer concurrent to their immunotherapy infusion (30 minutes). |
Timeline
- Start date
- 2020-01-31
- Primary completion
- 2020-10-01
- Completion
- 2020-10-01
- First posted
- 2019-10-15
- Last updated
- 2022-09-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04127318. Inclusion in this directory is not an endorsement.